Cargando…
A cost–utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy
INTRODUCTION: Biologic therapies have proven efficacious for patients with moderate-to-severe psoriasis. However, their economic value compared with standard of care in Italy has not been explored. This study estimates the cost-effectiveness of intermittent therapy with etanercept in patients with m...
Autores principales: | Colombo, Giorgio L, Di Matteo, Sergio, Peris, Ketty, Fargnoli, Maria Concetta, Esposito, Maria, Mazzotta, Annamaria, Chimenti, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169985/ https://www.ncbi.nlm.nih.gov/pubmed/21935307 |
Ejemplares similares
-
Moderate and severe plaque psoriasis: cost-of-illness study in Italy
por: Colombo, GL, et al.
Publicado: (2008) -
Combination therapy with etanercept in psoriasis: Retrospective analysis of efficacy and safety outcomes from real-life practice
por: Babino, Graziella, et al.
Publicado: (2016) -
Influence of body mass index and weight on etanercept efficacy in patients with psoriasis: A retrospective study
por: Giunta, Alessandro, et al.
Publicado: (2016) -
The CANOVA Study Real-World Evidence of Biologic Treatments in Moderate-Severe Psoriasis in Italy: A Gender Perspective
por: Colombo, Delia, et al.
Publicado: (2022) -
Treatment of psoriasis with etanercept in immunocompromised patients: Two case reports
por: De Simone, Clara, et al.
Publicado: (2016)